HomeBlog

Elisabeth Frausto, La Jolla Light, June 25, 2021

Dr. Doris Trauner is leading a CMCR clinical trial studying the effects of CBD on symptoms of severe autism in children. The study is currently enrolling participants and hopes to determine whether CBD reduces the problem behaviors seen in children with severe autism. Click here for a description of the study and link to a survey for those interested in participating.

Read the full La Jolla Light article here


 

The estate of Angela Ann Price has given CMCR a $100,000 gift to support medicinal cannabis research. This is the second donation of $100K the Price estate has given to CMCR. The gift will help support training opportunities for future leaders in cannabinoid science as well as support educational events, and could also provide seed funding to help investigators with the costs of their research. “We are extremely thankful for the Price estate’s continuing support of CMCR,” said Igor Grant, MD, CMCR Director. “These generous donations help CMCR to fulfill our mission of accelerating high quality scientific research in order to discover further insights into the medical safety and efficacy of cannabis.” Click here to learn more about supporting CMCR.

David Wharton, Los Angeles Times, July 2, 2021

CMCR investigators Drs. Mark Wallace and Donald Abrams comment on marijuana as a prohibited substance in Olympic trials.

Read the article here


 

Will Stone, KPBS, May 30, 2021

The DEA recently announced it will be issuing licenses to several manufacturers to grow cannabis for research studies. Prior to this decision, the University of Mississippi was the only Federally approved source for research cannabis products.

Read the full article here